The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of UGT1A4, UGT2B7, and UGT2B15 pharmacogenetics on tamoxifen (TAM) metabolism.
Joanne Siok-Liu Lim
No relevant relationships to disclose
Boian Ganchev
No relevant relationships to disclose
Onkar Singh
No relevant relationships to disclose
Thomas E Muerdter
No relevant relationships to disclose
Yoon Sim Yap
No relevant relationships to disclose
Raymond C.H. Ng
No relevant relationships to disclose
Nan Soon Wong
No relevant relationships to disclose
Matthias Schwab
No relevant relationships to disclose
Balram Chowbay
No relevant relationships to disclose